Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2025-12-24 @ 10:06 PM
NCT ID:
NCT06869135
Eligibility Criteria:
Inclusion Criteria:
* AD: standard criteria for dementia due to AD with AD neurochemical demonstration.
* PD: MDS Criteria; modified Hoehn\&Yahr stages; stable pharmacological treatment (last 4 weeks).
* AtP: current consensus diagnostic criteria for progressive supranuclear palsy; corticobasal degeneration and multiple system atrophy.
* prodromic PD: according to diagnostic criteria by Berg;
* MCI: according to diagnostic criteria by Dubois and Albert.
Exclusion Criteria:
* For all the experimental groups considered, subjects with concomitant chronic and / or inflammatory diseases of the oral cavity, other systemic diseases, oncological or infectious diseases will be excluded.
* Patients not able to provide written informed consent autonomously will be excluded.
* For PD patients: Vascular, familiar and drug- induced parkinsonism, other known or suspected causes (metabolic, brain tumor etc) or any suggestive features of AtP; dementia with MoCA Test Correct Score\<15
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Study:
NCT06869135
Study Brief:
Protocol Section:
NCT06869135